<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.10365.003</object-id><label>Table 1.</label><caption><p>The list of corrector drugs used in this study with their corresponding known primary MOAs (related to <xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.10365.003">http://dx.doi.org/10.7554/eLife.10365.003</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th><bold>Drugs of the CFBE dataset</bold> (<bold>Reference for correction activity</bold>)</th><th><bold>Primary Use/Class</bold></th> </tr></thead><tbody><tr><td>4-AN, PARP1 inhibitor (<xref ref-type="bibr" rid="bib3">Anjos et al., 2012</xref>)</td><td>PARP1 inhibitor</td></tr><tr><td>ABT888 (<xref ref-type="bibr" rid="bib3">Anjos et al., 2012</xref>)</td><td>A poly(ADP-ribose) polymerase (PARP)&#160;-1 and -2 inhibitor with chemosensitizing&#160;and antitumor activities. ABT-888 inhibits&#160;PARPs, thereby inhibiting DNA repair and&#160;potentiating the cytotoxicity of&#160;DNA-damaging agents.</td></tr><tr><td>Glafenine (<xref ref-type="bibr" rid="bib58">Robert et al., 2010</xref>)</td><td>An anthranilic acid derivative with&#160;analgesic properties used for the relief&#160;of all types of pain (1)</td></tr><tr><td>GSK339 (DY Thomas lab, unpublished)</td><td>Androgen receptor ligand (<xref ref-type="bibr" rid="bib49">Norris et al., 2009</xref>).</td></tr><tr><td>Ibuprofen (<xref ref-type="bibr" rid="bib11">Carlile et al., 2015</xref>)</td><td>Ibuprofen is a nonsteroidal&#160;anti-inflammatory drug. It is a non-selective inhibitor of cyclooxygenase.</td></tr><tr><td>JFD03094</td><td>PARP inhibitor</td></tr><tr><td>KM11060 (<xref ref-type="bibr" rid="bib59">Robert et al., 2008</xref>)</td><td>PDE5 inhibitor (an analog of sildenafil).</td></tr><tr><td>Latonduine (<xref ref-type="bibr" rid="bib10">Carlile et al., 2012</xref>)</td><td>PARP3 inhibitor</td></tr><tr><td>Minocycline H (D Y Thomas lab unpublished)</td><td>A tetracycline analog that inhibits&#160;protein synthesis in bacteria.&#160;Also known to inhibit 5-lipooxygenase&#160;in the brain (2).</td></tr><tr><td>Ouabagenin (<xref ref-type="bibr" rid="bib77">Zhang et al., 2012</xref>)</td><td>A cardiaoactive glycoside&#160;obtained from the seeds of&#160;<italic>Strophanthus gratus</italic>. Acts by inhibiting&#160;Na<sup>+</sup>/K<sup>+</sup>-ATPase, resulting in an&#160;increase in intracellular&#160;sodium and calcium concentrations (2).</td></tr><tr><td>Ouabain (<xref ref-type="bibr" rid="bib77">Zhang et al., 2012</xref>)</td><td>A cardiaoactive glycoside obtained&#160;from the seeds of <italic>Strophanthus gratus</italic>.&#160;Acts by inhibiting&#160;Na<sup>+</sup>/K<sup>+</sup>-ATPase, resulting in an increase&#160;in intracellular sodium and calcium<break/>concentrations (2).</td></tr><tr><td>PJ34 (<xref ref-type="bibr" rid="bib3">Anjos et al., 2012</xref>)</td><td>PARP1 inhibitor</td></tr><tr><td>Low temperature (<xref ref-type="bibr" rid="bib16">Denning et al., 1992</xref>)</td><td/></tr><tr><td>Chloramphenicol (<xref ref-type="bibr" rid="bib12">Carlile et al., 2007</xref>)</td><td>Inhibitor bacterial protein synthesis&#160;by binding to 23S rRNA and preventing&#160;peptidyl transferase activity (2).</td></tr><tr><td>Chlorzoxazone (<xref ref-type="bibr" rid="bib12">Carlile et al., 2007</xref>)</td><td>Muscle relaxant. Acts by inhibiting&#160;degranulation of mast cells and preventing&#160;the release of histamine and slow-reacting&#160;substance of anaphylaxis. It acts at the&#160;level of the spinal cord and subcortical&#160;areas of the brain where it inhibits&#160;multi-synaptic reflex arcs involved in&#160;producing and maintaining skeletal&#160;muscle spasm (2).</td></tr><tr><td>Dexamethasone (<xref ref-type="bibr" rid="bib9">Caohuy et al., 2009</xref>)</td><td>A synthetic glucocorticoid agonist.&#160;Its anti-inflammatory properties are&#160;thought to involve phospholipase A<sub>2&#160;</sub>inhibitory proteins, lipocortins (2).</td></tr><tr><td>Doxorubicin (<xref ref-type="bibr" rid="bib44">Maitra et al., 2001</xref>)</td><td>DNA intercalator that inhibits&#160;topoisomerase II activity by&#160;stabilizing the DNA-topoisomerase&#160;II complex (2).</td></tr><tr><td>Glafenine (<xref ref-type="bibr" rid="bib58">Robert et al., 2010</xref>)</td><td>An anthranilic acid derivative with&#160;analgesic properties used for the relief&#160;of all types of pain (1).</td></tr><tr><td>Liothyronine (<xref ref-type="bibr" rid="bib12">Carlile et al., 2007</xref>)</td><td>L-triiodothyronine (T3, liothyronine)&#160;thyroid hormone is normally synthesized&#160;and secreted by the thyroid gland.&#160;Most T3 is derived from peripheral&#160;monodeiodination of T4<break/>(L-tetraiodothyronine, levothyroxine, L-thyroxine). The hormone finally delivered and used by the tissues is mainly T3. Liothyronine acts on the body to increase the basal metabolic rate, affect protein synthesis and increase the body's sensitivity to catecholamines (such as adrenaline). It is used to treat hypothyroidism (2).</td></tr><tr><td>MS-275 (<xref ref-type="bibr" rid="bib31">Hutt et al., 2010</xref>)</td><td>Also known as Entinostat. An inhibitor of Class Ihistone deacetylases (preferentially HDAC 1, also HDAC 3) (<xref ref-type="bibr" rid="bib30">Hu et al., 2003</xref>).</td></tr><tr><td>Scriptaid (<xref ref-type="bibr" rid="bib31">Hutt et al., 2010</xref>)</td><td>An inhibitor of Class I histone deacetylases (HDAC1, HDAC3 and HDAC8) (<xref ref-type="bibr" rid="bib30">Hu et al., 2003</xref>).</td></tr><tr><td>Strophanthidin (<xref ref-type="bibr" rid="bib12">Carlile et al., 2007</xref>)</td><td>A cardioactive glycoside that inhibits Na<sup>+</sup>/K<sup>+</sup>-ATPase. Also known to inhibit the interaction of MDM2 and MDMX (1).</td></tr><tr><td>Thapsigargin (<xref ref-type="bibr" rid="bib17">Egan et al., 2002</xref>)</td><td>A sesquiterpene lactone found in roots of <italic>Thapsia garganica</italic>. A non-competitive inhibitor of sarco/endoplasmic Ca<sup>2+</sup>-ATPase (SERCA) (1).</td></tr><tr><td>Trichostatin-A (<xref ref-type="bibr" rid="bib31">Hutt et al., 2010</xref>)</td><td>An inhibitor of histone deacetylases (HDAC1, HDAC3, HDAC8 and HDAC7) (<xref ref-type="bibr" rid="bib30">Hu et al., 2003</xref>).</td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><p>(1) <ext-link ext-link-type="uri" xlink:href="http://pubchem.ncbi.nlm.nih.gov/">http://pubchem.ncbi.nlm.nih.gov/</ext-link></p> </fn><fn id="tblfn2"><p>(2) <ext-link ext-link-type="uri" xlink:href="www.drugbank.ca">www.drugbank.ca</ext-link></p> </fn></table-wrap-foot></table-wrap>